Roche’s Early Alzheimer’s Blood Test Gets FDA Breakthrough Device Designation
XTalks
APRIL 18, 2024
This test, which is being co-developed with Eli Lilly, has the potential to facilitate earlier and more accurate detection of the disease. Roche and Eli Lilly announced their partnership to develop the assay last year in March, which included launching a two-year clinical trial involving hundreds of volunteers.
Let's personalize your content